Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Neuroblastoma 28Glioblastoma 16Gliosarcoma 12Central Nervous System Neoplasms 10Brain Neoplasms 10Astrocytoma 10Glioma 7Oligodendroglioma 6Medulloblastoma 5Ganglioneuroblastoma 5Lymphoma 4Familial ependymoma 4Ependymoma 4Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroectodermal Tumors, Primitive 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Wilms Tumor 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Sezary Syndrome 2Rhabdoid Tumor 2Ovarian Neoplasms 2

Interventions

avapritinib 2Imatinib Mesylate 2trametinib 1sargramostim 1ripretinib 1guadecitabine 1dabrafenib 1Trabectedin 1Thalidomide 1Specimen Handling 1Oxaliplatin 1Nivolumab 1Midazolam 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Ipilimumab 1Floxuridine 1Fentanyl 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Cetuximab 1Capecitabine 1CTLA-4 Antigen 17-hydroxystaurosporine 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × sargramostim × CNS × Clear all
NCT00069940 2010-12-28

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Dana-Farber Cancer Institute

Phase 1 Completed
CNSGastrointestinalSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Leiomyosarcoma, Liposarcoma, Oligodendroglioma, Sarcoma, Sarcoma, Synovial, Central Nervous System Neoplasms, Gliosarcoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡